Current Concepts in the Management of Allergic Fungal Rhinosinusitis

Matthew A. Tyler; Amber U. Luong

doi:10.1016/j.iac.2019.12.001

Current Concepts in the Management of Allergic Fungal Rhinosinusitis

Matthew A. Tyler, Amber U. Luong

Otolaryngology

Research output: Contribution to journal › Review article › peer-review

11 Scopus citations

Abstract

Allergic fungal rhinosinusitis (AFRS) represents a subtype of chronic rhinosinusitis with nasal polyposis that exhibits a unique, often striking clinical presentation. Since its initial description more than a quarter century ago, a more sophisticated understanding of the pathophysiology of AFRS has been achieved and significant advancements in improving clinical outcomes made. This review focuses on the latest developments involving the pathophysiology and clinical management of this fascinating disease.

Original language	English (US)
Pages (from-to)	345-359
Number of pages	15
Journal	Immunology and Allergy Clinics of North America
Volume	40
Issue number	2
DOIs	https://doi.org/10.1016/j.iac.2019.12.001
State	Published - May 2020

Bibliographical note

Funding Information:
A.U. Luong serves as a consultant for Aerin Medical (Sunnyvale, California), Arrinex (Redwood City, California), Lyra Therapeutics (Watertown, Massachusetts), and Stryker (Kalamazoo, Michigan). She is on the advisory board for ENTvantage (Austin, Texas), Sanofi (Paris, France), and Novartis (Basel, Switzerland).

Publisher Copyright:
© 2019 Elsevier Inc.

Keywords

Allergic fungal rhinosinusitis
Allergic sinusitis
Chronic rhinosinusitis
Eosinophilic mucin rhinosinusitis
Fungal allergy
Fungal sinusitis
Nasal polyps
Type 2 inflammation

PubMed: MeSH publication types

Journal Article
Review

Access

10.1016/j.iac.2019.12.001

OpenUrl availability

Full text

Cite this

@article{9ef4d331f79f47f8aa8a9c3149279b09,

title = "Current Concepts in the Management of Allergic Fungal Rhinosinusitis",

abstract = "Allergic fungal rhinosinusitis (AFRS) represents a subtype of chronic rhinosinusitis with nasal polyposis that exhibits a unique, often striking clinical presentation. Since its initial description more than a quarter century ago, a more sophisticated understanding of the pathophysiology of AFRS has been achieved and significant advancements in improving clinical outcomes made. This review focuses on the latest developments involving the pathophysiology and clinical management of this fascinating disease.",

keywords = "Allergic fungal rhinosinusitis, Allergic sinusitis, Chronic rhinosinusitis, Eosinophilic mucin rhinosinusitis, Fungal allergy, Fungal sinusitis, Nasal polyps, Type 2 inflammation",

author = "Tyler, {Matthew A.} and Luong, {Amber U.}",

note = "Funding Information: A.U. Luong serves as a consultant for Aerin Medical (Sunnyvale, California), Arrinex (Redwood City, California), Lyra Therapeutics (Watertown, Massachusetts), and Stryker (Kalamazoo, Michigan). She is on the advisory board for ENTvantage (Austin, Texas), Sanofi (Paris, France), and Novartis (Basel, Switzerland). Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2020",

month = may,

doi = "10.1016/j.iac.2019.12.001",

language = "English (US)",

volume = "40",

pages = "345--359",

journal = "Immunology and Allergy Clinics of North America",

issn = "0889-8561",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Current Concepts in the Management of Allergic Fungal Rhinosinusitis

AU - Tyler, Matthew A.

AU - Luong, Amber U.

N1 - Funding Information: A.U. Luong serves as a consultant for Aerin Medical (Sunnyvale, California), Arrinex (Redwood City, California), Lyra Therapeutics (Watertown, Massachusetts), and Stryker (Kalamazoo, Michigan). She is on the advisory board for ENTvantage (Austin, Texas), Sanofi (Paris, France), and Novartis (Basel, Switzerland). Publisher Copyright: © 2019 Elsevier Inc.

PY - 2020/5

Y1 - 2020/5

N2 - Allergic fungal rhinosinusitis (AFRS) represents a subtype of chronic rhinosinusitis with nasal polyposis that exhibits a unique, often striking clinical presentation. Since its initial description more than a quarter century ago, a more sophisticated understanding of the pathophysiology of AFRS has been achieved and significant advancements in improving clinical outcomes made. This review focuses on the latest developments involving the pathophysiology and clinical management of this fascinating disease.

AB - Allergic fungal rhinosinusitis (AFRS) represents a subtype of chronic rhinosinusitis with nasal polyposis that exhibits a unique, often striking clinical presentation. Since its initial description more than a quarter century ago, a more sophisticated understanding of the pathophysiology of AFRS has been achieved and significant advancements in improving clinical outcomes made. This review focuses on the latest developments involving the pathophysiology and clinical management of this fascinating disease.

KW - Allergic fungal rhinosinusitis

KW - Allergic sinusitis

KW - Chronic rhinosinusitis

KW - Eosinophilic mucin rhinosinusitis

KW - Fungal allergy

KW - Fungal sinusitis

KW - Nasal polyps

KW - Type 2 inflammation

UR - http://www.scopus.com/inward/record.url?scp=85078520334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85078520334&partnerID=8YFLogxK

U2 - 10.1016/j.iac.2019.12.001

DO - 10.1016/j.iac.2019.12.001

M3 - Review article

C2 - 32278456

AN - SCOPUS:85078520334

SN - 0889-8561

VL - 40

SP - 345

EP - 359

JO - Immunology and Allergy Clinics of North America

JF - Immunology and Allergy Clinics of North America

IS - 2

ER -

Current Concepts in the Management of Allergic Fungal Rhinosinusitis

Abstract

Bibliographical note

Keywords

PubMed: MeSH publication types

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this